Table 4.
Compounds | Docking Scores (Pks13) |
MIC (µg/ml) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Index | Name | LS1 | LS2 | −PLP1 | −PLP2 | Jain | −PMF | −PMF04 | −CDE | −CDIE | TBE | HRv | MDR |
1 | 3a | 4.1 | 6.55 | 103.24 | 100.61 | 1.97 | 134.25 | 63.43 | 27.205 | 46.07 | −12.47 | 8 | 16 |
2 | 3b | 5.11 | 6.62 | 117.68 | 107.52 | 2.85 | 126.69 | 76.55 | 29.426 | 47.451 | −14.73 | 32 | 32 |
3 | 3c | 4.72 | 6.92 | 112.79 | 106.22 | 4.53 | 143.21 | 74.55 | 27.984 | 51.551 | −8.15 | 11 | NA |
4 | 3d | 5.17 | 6.94 | 121.61 | 109.44 | 4.42 | 138.38 | 100.74 | 29.526 | 49.428 | −17.05 | 8 | 32 |
5 | 3e | 4.87 | 7.09 | 125.76 | 116.1 | 4.26 | 122.99 | 79.43 | 36.391 | 53.449 | −20.64 | 32 | 128 |
6 | 3f | 3.74 | 6.87 | 125.62 | 110.37 | 2.35 | 118.28 | 75.77 | 31.371 | 49.573 | −6.19 | 128 | NA |
7 | 3g | 4.64 | 6.62 | 112.53 | 102.85 | 3.81 | 143.89 | 74.97 | 31.856 | 49 | −14.66 | 32 | NA |
8 | 3h | 3.97 | 6.9 | 119.25 | 107.77 | 2.64 | 133.66 | 71.53 | 30.655 | 49.581 | −28.07 | 64 | NA |
9 | 3i | 3.89 | 6.91 | 103.89 | 99.06 | 3.74 | 137.41 | 75.08 | 31.567 | 47.857 | −18.80 | 11.3 | NA |
Co-crystallized ligand | 5.25 | 7.01 | 133.07 | 129.46 | 6.87 | 106.85 | 80.85 | 27.53 | 56.49 | ||||
RD* score (3a) | 0.78 | 0.93 | 0.78 | 0.78 | 0.29 | 1.26 | 0.79 | 0.99 | 0.82 | ||||
RD score (3d) | 0.99 | 0.99 | 0.91 | 0.85 | 0.64 | 1.30 | 1.25 | 1.07 | 0.88 |
*RD score = compound’s score/redocked co-crystallized ligand score.